FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34306611000001101: Baricitinib (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2017. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    103841501000001111 Baricitinib (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    103841601000001110 Baricitinib en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Baricitinib Is a Substance with Janus kinase inhibitor mechanism of action false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Baricitinib 4mg tablets Has specific active ingredient False Baricitinib Inferred relationship Existential restriction modifier
    Olumiant 4mg tablets (Eli Lilly and Company Ltd) Has specific active ingredient False Baricitinib Inferred relationship Existential restriction modifier
    Baricitinib 4mg tablets 28 tablet Has specific active ingredient False Baricitinib Inferred relationship Existential restriction modifier
    Olumiant 4mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient False Baricitinib Inferred relationship Existential restriction modifier
    Baricitinib 2mg tablets Has specific active ingredient False Baricitinib Inferred relationship Existential restriction modifier
    Olumiant 2mg tablets (Eli Lilly and Company Ltd) Has specific active ingredient False Baricitinib Inferred relationship Existential restriction modifier
    Baricitinib 2mg tablets 28 tablet Has specific active ingredient False Baricitinib Inferred relationship Existential restriction modifier
    Olumiant 2mg tablets (Eli Lilly and Company Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient False Baricitinib Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start